Citadel Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4M Buy
1,027,863
+797,642
+346% +$10.4M ﹤0.01% 1193
2025
Q1
$5.81M Sell
230,221
-763,946
-77% -$19.3M ﹤0.01% 1636
2024
Q4
$34.2M Buy
994,167
+782,424
+370% +$26.9M 0.01% 697
2024
Q3
$10.5M Buy
211,743
+84,253
+66% +$4.16M ﹤0.01% 1225
2024
Q2
$7.67M Sell
127,490
-3,789
-3% -$228K ﹤0.01% 1390
2024
Q1
$6.77M Buy
131,279
+22,952
+21% +$1.18M ﹤0.01% 1548
2023
Q4
$4.37M Buy
108,327
+105,526
+3,767% +$4.25M ﹤0.01% 1744
2023
Q3
$78.1K Sell
2,801
-255,473
-99% -$7.13M ﹤0.01% 4927
2023
Q2
$7.44M Buy
258,274
+211,154
+448% +$6.08M ﹤0.01% 1411
2023
Q1
$786K Buy
47,120
+38,683
+458% +$645K ﹤0.01% 3425
2022
Q4
$107K Sell
8,437
-15,459
-65% -$196K ﹤0.01% 4985
2022
Q3
$287K Sell
23,896
-6,092
-20% -$73.2K ﹤0.01% 4579
2022
Q2
$422K Buy
+29,988
New +$422K ﹤0.01% 4313